Works matching DE "PANITUMUMAB"
Results: 89
Panitumumab w leczeniu chorych na raka jelita grubego.
- Published in:
- Gastroenterologia Kliniczna, 2022, v. 14, n. 4, p. 139
- By:
- Publication type:
- Article
Case report: a rare case of colorectal cancer diagnosed in a young pregnant woman – management and evolution.
- Published in:
- Oncolog-Hematolog, 2024, v. 69, n. 4, p. 28
- By:
- Publication type:
- Article
EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040499
- By:
- Publication type:
- Article
Use of monoclonal antibodies (Bevacizumab, Cetuximab, and Panitumumab) in patients with metastatic colorectal cancer: A single center experience.
- Published in:
- Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2022, v. 39, n. 4, p. 1112, doi. 10.52142/omujecm.39.4.34
- By:
- Publication type:
- Article
Editorial: Optimizing the first-line treatment for metastatic colorectal cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1366383
- By:
- Publication type:
- Article
LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases--a phase II study.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1231600
- By:
- Publication type:
- Article
Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer .
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1138357
- By:
- Publication type:
- Article
Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1147497
- Publication type:
- Article
Case report: Long-term survival in a patient with metastatic colorectal cancer treated with trifluridine/tipiracil in the third-line setting.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1112224
- By:
- Publication type:
- Article
Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2023.1084681
- By:
- Publication type:
- Article
Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic colorectal cancer: Subgroup analysis of patients treated within the PanaMa trial (AIO KRK 0212).
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 5, p. 863, doi. 10.1002/ijc.34760
- By:
- Publication type:
- Article
Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 3, p. 488, doi. 10.1002/ijc.34733
- By:
- Publication type:
- Article
Panitumumab plus trifluridine/tipiracil as anti‐EGFR rechallenge therapy in patients with refractory RAS wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase II VELO trial.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 8, p. 1520, doi. 10.1002/ijc.34632
- By:
- Publication type:
- Article
Multicenter, single‐arm, phase II study of the continuous use of panitumumab in combination with FOLFIRI after FOLFOX for RAS wild‐type metastatic colorectal cancer: Exploratory sequential examination of acquired mutations in circulating cell‐free DNA
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 12, p. 2172, doi. 10.1002/ijc.34184
- By:
- Publication type:
- Article
Early onset metastatic colorectal cancer in patients receiving panitumumab‐based upfront strategy: Overall and sex‐specific outcomes in the Valentino trial.
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 10, p. 1760, doi. 10.1002/ijc.34156
- By:
- Publication type:
- Article
Aphthous-Like Stomatitis in a Patient Receiving Panitumumab.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
The potential effect of Schisandrin‐B combination with panitumumab in wild‐type and mutant colorectal cancer cell lines: Role of apoptosis and autophagy.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2023, v. 37, n. 5, p. 1, doi. 10.1002/jbt.23324
- By:
- Publication type:
- Article
Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2022, v. 71, n. 8, p. 1877, doi. 10.1007/s00262-021-03124-x
- By:
- Publication type:
- Article
A comparison of panitumumab and cetuximab in the treatment of KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
- Published in:
- Immunopharmacology & Immunotoxicology, 2023, v. 45, n. 1, p. 1, doi. 10.1080/08923973.2022.2112222
- By:
- Publication type:
- Article
Drug-induced thrombocytopenia in a patient with colorectal cancer: A case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Evaluation of physicochemical and functional similarity of a new CHO derived anti-EGFR antibody P-mAb to its reference medicinal product.
- Published in:
- Artificial Cells, Nanomedicine & Biotechnology, 2022, v. 50, n. 1, p. 17, doi. 10.1080/21691401.2022.2028284
- By:
- Publication type:
- Article
Panitumumab-Associated Drug-Induced Immune Thrombocytopenia in a Patient with Colorectal Cancer.
- Published in:
- Case Reports in Oncology, 2021, v. 14, n. 1, p. 85, doi. 10.1159/000512821
- By:
- Publication type:
- Article
A Patient with Transverse Colon Cancer Complicated by Cowden Syndrome Administered FOLFOXIRI + Bevacizumab Therapy.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
MONARCC: a randomised phase II study of panitumumab monotherapy and panitumumab plus 5-fluorouracil as first-line therapy for RAS and BRAF wildtype metastatic colorectal cancer: a study by the Australasian Gastrointestinal Trials Group (AGITG).
- Published in:
- 2021
- By:
- Publication type:
- journal article
REMARRY and PURSUIT trials: liquid biopsy-guided rechallenge with anti-epidermal growth factor receptor (EGFR) therapy with panitumumab plus irinotecan for patients with plasma RAS wild-type metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancer.
- Published in:
- International Journal of Colorectal Disease, 2021, v. 36, n. 12, p. 2621, doi. 10.1007/s00384-021-04002-9
- By:
- Publication type:
- Article
A prospective, single-arm, multicenter trial of neoadjuvant chemotherapy with mFOLFOX6 plus panitumumab without radiotherapy for locally advanced rectal cancer.
- Published in:
- International Journal of Colorectal Disease, 2020, v. 35, n. 12, p. 2197, doi. 10.1007/s00384-020-03693-w
- By:
- Publication type:
- Article
Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.1027890
- By:
- Publication type:
- Article
The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.1015510
- By:
- Publication type:
- Article
MYC Gene Mutations as Causative Pathways for Development and Treatment of Hematological Malignancies.
- Published in:
- Indian Journal of Forensic Medicine & Toxicology, 2022, v. 16, n. 1, p. 1689, doi. 10.37506/ijfmt.v16i1.17814
- By:
- Publication type:
- Article
Erratum: Funding Acknowledgment.
- Published in:
- Journal of Clinical Practice & Research, 2023, v. 45, n. 4, p. 426, doi. 10.14744/cpr.2023.21931
- Publication type:
- Article
Miller Fisher Syndrome and Cavernous Sinus Thrombosis Caused by Sinusitis.
- Published in:
- Journal of Clinical Practice & Research, 2023, v. 45, n. 4, p. 424, doi. 10.14744/cpr.2023.43531
- By:
- Publication type:
- Article
Panitumumab Induced Paronychia and Trichomegaly.
- Published in:
- Journal of Clinical Practice & Research, 2023, v. 45, n. 4, p. 422, doi. 10.14744/etd.2023.78646
- By:
- Publication type:
- Article
Cancer therapy related cardiac dysfunction as a result of Panitumumab.
- Published in:
- Cardio-Oncology, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s40959-024-00223-3
- By:
- Publication type:
- Article
FDA Approves Sotorasib With Panitumumab for KRAS G12C-Variant Colorectal Cancer.
- Published in:
- ONS Voice, 2025, p. 2
- Publication type:
- Article
Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-21582-w
- By:
- Publication type:
- Article
Anti-cancer treatment schedule optimization based on tumor dynamics modelling incorporating evolving resistance.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08012-7
- By:
- Publication type:
- Article
Efficacy of Panitumumab and Cetuximab in Patients with Colorectal Cancer Previously Treated with Bevacizumab; a Combined Analysis of Individual Patient Data from ASPECCT and WJOG6510G.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1715, doi. 10.3390/cancers12071715
- By:
- Publication type:
- Article
Sotorasib Combo Bests Chemo Leading to Approval in KRAS G12C+ CRC.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 85
- By:
- Publication type:
- Article
Navigating metastatic colorectal treatment options in the USA: a survey of patient acceptance of skin toxicities associated with Vectibix.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 11, p. 6731, doi. 10.1007/s00520-021-06134-8
- By:
- Publication type:
- Article
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 7, p. 3971, doi. 10.1007/s00520-020-05972-2
- By:
- Publication type:
- Article
Efficacy and Safety of Panitumumab in Patients With RAF/RAS-Wild-Type Glioblastoma: Results From the Drug Rediscovery Protocol.
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 431, doi. 10.1093/oncolo/oyad320
- By:
- Publication type:
- Article
Phase Ib/II Study of the Efficacy and Safety of Binimetinib (MEK162) Plus Panitumumab for Mutant or Wild-Type RAS Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 12, p. e1209, doi. 10.1093/oncolo/oyad210
- By:
- Publication type:
- Article
The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.
- Published in:
- Oncologist, 2023, v. 28, n. 7, p. e565, doi. 10.1093/oncolo/oyac145
- By:
- Publication type:
- Article
Impact of Systemic Treatments on Outcomes and Quality of Life in Patients with RAS-Positive Stage IV Colorectal Cancer: A Systematic Review.
- Published in:
- Diseases, 2024, v. 12, n. 4, p. 79, doi. 10.3390/diseases12040079
- By:
- Publication type:
- Article
The Conundrum of Cancer-Associated Thrombosis: Lesson Learned from Two Intriguing Cases and Literature Review.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Use of Circulating Tumor DNA to Monitor Minimal Residual Disease Among Patients With Colorectal Cancer.
- Published in:
- Clinical Journal of Oncology Nursing, 2023, v. 27, n. 4, p. 369, doi. 10.1188/23.CJON.369-374
- By:
- Publication type:
- Article
Intravitreal panitumumab for prevention of myopic axial elongation in highly myopic adult eyes with myopic macular degeneration: Phase 1 study on safety.
- Published in:
- Acta Ophthalmologica (1755375X), 2022, v. 100, p. N.PAG, doi. 10.1111/j.1755-3768.2022.0240
- By:
- Publication type:
- Article
Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With or Without Panitumumab in Patients With Advanced Urothelial Carcinoma: Multicenter, Randomized, French Unicancer GETUG/AFU 19 Study.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 4, p. e216, doi. 10.1016/j.clgc.2021.02.005
- Publication type:
- Article
A marginalized two‐part joint model for a longitudinal biomarker and a terminal event with application to advanced head and neck cancers.
- Published in:
- Pharmaceutical Statistics, 2024, v. 23, n. 1, p. 60, doi. 10.1002/pst.2338
- By:
- Publication type:
- Article